These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2013-002980-24 Comparative study to evaluate the effect on platelet aggregation of two different doses (20 and 40 mg) of acetylsalicylic acid administered sublingually compared to the dose of 100 mg of acetylsalicyl... not-yet-due
Completed, but no date 2016-000973-19 OVERNIGHT SWITCH FROM RASAGILINE TO SAFINAMIDE IN FLUCTUATING PATIENTS WITH PARKINSON’S DISEASE: A TOLERABILITY AND SAFETY STUDY STUDIO DI SICUREZZA E TOLLERABILITA’ SUL CAMBIO IMMEDIATO (OVERNIGHT... bad-data
Completed, but no date 2018-004112-21 TOLERABILITY, SAFETY AND EFFICACY OF VORTIOXETINE FOR TREATMENT OF DEPRESSION IN PARKINSON’S DISEASE: A 16 WEEK OPEN LABEL STUDY STUDIO IN APERTO PER VALUTARE TOLLERABILITA’, SICUREZZA ED EFFICACIA... bad-data
Not reported 2019-001491-11 Phase IV study for efficacy and safety of Evolocumab added to Ezetimibe (Standard of Care) in high cardiovascular risk haemodialized statin intolerant patients with hypercholesterolemia. Studio di ... 2022-03-14 due-trials